VYGR Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 | Ferguson Toby | officer: Chief Medical Officer | 105,000 | A-Award | A | 105,000 | 0.00 | 0.00 |
| 2024-04-02 | Swartz Robin | officer: Chief Operating Officer | 117,004 | S-Sale | D | 1,357 | 9.88 | 13,407.00 |
| 2024-04-02 | Sandrock Alfred | director, officer: President and CEO | 322,839 | S-Sale | D | 12,115 | 9.86 | 119,454.00 |
| 2024-03-25 | Ferguson Toby | officer: Chief Medical Officer | 210,000 | A-Award | A | 210,000 | 9.26 | 1,944,600.00 |
| 2024-03-25 | Ferguson Toby | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2024-02-21 | Swartz Robin | officer: Chief Operating Officer | 118,361 | S-Sale | D | 3,966 | 7.45 | 29,547.00 |
| 2024-02-21 | Sandrock Alfred | director, officer: President and CEO | 334,954 | S-Sale | D | 13,033 | 7.46 | 97,226.00 |
| 2024-02-21 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 175,669 | S-Sale | D | 3,764 | 7.46 | 28,079.00 |
| 2024-02-20 | Carter Todd Alfred | officer: Chief Scientific Officer | 90,992 | S-Sale | D | 602 | 7.68 | 4,623.00 |
| 2024-02-21 | Carter Todd Alfred | officer: Chief Scientific Officer | 87,627 | S-Sale | D | 3,365 | 7.47 | 25,137.00 |
| 2024-02-09 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 92,000 | A-Award | A | 31,000 | 0.00 | 0.00 |
| 2024-02-09 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 62,000 | A-Award | A | 62,000 | 7.60 | 471,200.00 |
| 2024-02-09 | Carter Todd Alfred | officer: Chief Scientific Officer | 91,594 | A-Award | A | 38,500 | 0.00 | 0.00 |
| 2024-02-09 | Carter Todd Alfred | officer: Chief Scientific Officer | 77,000 | A-Award | A | 77,000 | 7.60 | 585,200.00 |
| 2024-02-09 | Swartz Robin | officer: Chief Operating Officer | 122,327 | A-Award | A | 50,000 | 0.00 | 0.00 |
| 2024-02-09 | Swartz Robin | officer: Chief Operating Officer | 100,000 | A-Award | A | 100,000 | 7.60 | 760,000.00 |
| 2024-02-09 | Sandrock Alfred | director, officer: President and CEO | 347,987 | A-Award | A | 130,000 | 0.00 | 0.00 |
| 2024-02-09 | Sandrock Alfred | director, officer: President and CEO | 260,000 | A-Award | A | 260,000 | 7.60 | 1,976,000.00 |
| 2024-02-09 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 179,433 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2024-02-09 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 60,000 | A-Award | A | 60,000 | 7.60 | 456,000.00 |
| 2024-01-17 | Swartz Robin | officer: Chief Operating Officer | 72,327 | S-Sale | D | 2,543 | 7.15 | 18,182.00 |
| 2024-01-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 53,094 | S-Sale | D | 1,266 | 7.18 | 9,090.00 |
| 2023-10-03 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 149,433 | S-Sale | D | 13,567 | 6.99 | 94,833.00 |
| 2023-10-01 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 61,000 | A-Award | A | 61,000 | 0.00 | 0.00 |
| 2023-09-15 | Carter Todd Alfred | officer: Chief Scientific Officer | 64,860 | M-Exempt | A | 5,000 | 2.85 | 14,250.00 |
| 2023-09-15 | Carter Todd Alfred | officer: Chief Scientific Officer | 54,360 | S-Sale | D | 10,500 | 8.16 | 85,680.00 |
| 2023-09-15 | Carter Todd Alfred | officer: Chief Scientific Officer | 40,000 | M-Exempt | D | 5,000 | 2.85 | 14,250.00 |
| 2023-07-10 | Fahey Sandell Jacquelyn | officer: Chief Legal Officer | 122,000 | A-Award | A | 122,000 | 10.18 | 1,241,960.00 |
| 2023-07-10 | Fahey Sandell Jacquelyn | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-07-06 | Carter Todd Alfred | officer: Chief Scientific Officer | 59,860 | S-Sale | D | 5,500 | 10.80 | 59,400.00 |
| 2023-06-30 | Carter Todd Alfred | officer: Chief Scientific Officer | 70,360 | M-Exempt | A | 5,000 | 2.85 | 14,250.00 |
| 2023-06-30 | Carter Todd Alfred | officer: Chief Scientific Officer | 65,360 | S-Sale | D | 5,000 | 11.41 | 57,050.00 |
| 2023-06-30 | Carter Todd Alfred | officer: Chief Scientific Officer | 45,000 | M-Exempt | D | 5,000 | 2.85 | 14,250.00 |
| 2023-06-06 | PIERCE GLENN | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | MACKEY CATHERINE J | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | Vitale Nancy | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | Onyia Jude | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | Higgins Michael J | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | Colon Grace | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | GERAGHTY JAMES A | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | SCANGOS GEORGE A | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-06-06 | Hyman Steven | director | 22,000 | A-Award | A | 22,000 | 12.57 | 276,540.00 |
| 2023-05-09 | SCANGOS GEORGE A | director | 44,000 | A-Award | A | 44,000 | 10.76 | 473,440.00 |
| 2023-05-09 | SCANGOS GEORGE A | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-04-03 | Sandrock Alfred | director, officer: President and CEO | 214,618 | S-Sale | D | 7,437 | 7.83 | 58,232.00 |
| 2023-04-03 | Swartz Robin | officer: Chief Operating Officer | 71,617 | S-Sale | D | 1,259 | 7.83 | 9,858.00 |
| 2023-03-15 | Swartz Robin | officer: Chief Operating Officer | 76,530 | S-Sale | D | 15,373 | 8.20 | 126,059.00 |
| 2023-02-23 | Onyia Jude | director | 44,000 | A-Award | A | 44,000 | 6.92 | 304,480.00 |
| 2023-02-23 | Onyia Jude | director | 2,910 | D | 0 | 0.00 | 0.00 | |
| 2023-02-23 | NEUROCRINE BIOSCIENCES INC | 10 percent owner | 8,575,316 | P-Purchase | A | 4,395,588 | 8.88 | 39,032,821.00 |
| 2023-02-17 | Hesslein Robert W. | officer: Senior VP & General Counsel | 106,610 | S-Sale | D | 3,297 | 7.45 | 24,563.00 |
| 2023-02-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 68,291 | A-Award | A | 34,000 | 0.00 | 0.00 |
| 2023-02-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 68,000 | A-Award | A | 68,000 | 7.43 | 505,240.00 |
| 2023-02-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 67,553 | S-Sale | D | 738 | 7.45 | 5,498.00 |
| 2023-02-17 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 163,000 | A-Award | A | 38,000 | 0.00 | 0.00 |
| 2023-02-17 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 76,000 | A-Award | A | 76,000 | 7.43 | 564,680.00 |
| 2023-02-17 | Swartz Robin | officer: Chief Operating Officer | 91,903 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2023-02-17 | Swartz Robin | officer: Chief Operating Officer | 80,000 | A-Award | A | 80,000 | 7.43 | 594,400.00 |
| 2023-02-17 | Sandrock Alfred | director, officer: President and CEO | 240,000 | A-Award | A | 240,000 | 7.43 | 1,783,200.00 |
| 2023-02-17 | Sandrock Alfred | director, officer: President and CEO | 222,055 | A-Award | A | 120,000 | 0.00 | 0.00 |
| 2023-02-13 | Carter Todd Alfred | officer: Chief Scientific Officer | 34,291 | S-Sale | D | 797 | 7.67 | 6,113.00 |
| 2023-02-13 | Hesslein Robert W. | officer: Senior VP & General Counsel | 109,907 | S-Sale | D | 2,868 | 7.67 | 21,998.00 |
| 2023-02-02 | Third Rock Ventures III, L.P. | 10 percent owner | 3,185,291 | J-Other | D | 1,500,000 | 0.00 | 0.00 |
| 2023-01-30 | Third Rock Ventures III, L.P. | 10 percent owner | 4,998,933 | S-Sale | D | 75,000 | 9.03 | 677,250.00 |
| 2023-01-31 | Third Rock Ventures III, L.P. | 10 percent owner | 4,813,933 | S-Sale | D | 185,000 | 9.25 | 1,711,250.00 |
| 2023-02-01 | Third Rock Ventures III, L.P. | 10 percent owner | 4,685,291 | S-Sale | D | 128,642 | 9.32 | 1,198,943.00 |
| 2023-01-27 | Third Rock Ventures III, L.P. | director | 5,073,933 | S-Sale | D | 50,000 | 9.02 | 451,000.00 |
| 2023-01-24 | Third Rock Ventures III, L.P. | director | 5,173,933 | S-Sale | D | 100,000 | 9.27 | 927,000.00 |
| 2023-01-25 | Third Rock Ventures III, L.P. | director | 5,123,933 | S-Sale | D | 50,000 | 9.22 | 461,000.00 |
| 2023-01-20 | Third Rock Ventures III, L.P. | director | 5,328,933 | S-Sale | D | 100,000 | 9.15 | 915,000.00 |
| 2023-01-23 | Third Rock Ventures III, L.P. | director | 5,273,933 | S-Sale | D | 55,000 | 9.06 | 498,300.00 |
| 2023-01-17 | Hesslein Robert W. | officer: Senior VP & General Counsel | 113,567 | S-Sale | D | 1,396 | 9.57 | 13,360.00 |
| 2023-01-17 | Hesslein Robert W. | officer: Senior VP & General Counsel | 112,775 | S-Sale | D | 792 | 10.34 | 8,189.00 |
| 2023-01-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 35,488 | S-Sale | D | 706 | 9.57 | 6,756.00 |
| 2023-01-17 | Carter Todd Alfred | officer: Chief Scientific Officer | 35,088 | S-Sale | D | 400 | 10.34 | 4,136.00 |
| 2023-01-17 | Swartz Robin | officer: Chief Operating Officer | 52,695 | S-Sale | D | 1,396 | 9.57 | 13,360.00 |
| 2023-01-17 | Swartz Robin | officer: Chief Operating Officer | 51,903 | S-Sale | D | 792 | 10.34 | 8,189.00 |
| 2023-01-09 | EcoR1 Capital, LLC | director | 4,297,907 | S-Sale | D | 456,000 | 7.67 | 3,498,295.00 |
| 2023-01-10 | EcoR1 Capital, LLC | director | 3,961,507 | S-Sale | D | 336,400 | 8.05 | 2,709,433.00 |
| 2023-01-11 | EcoR1 Capital, LLC | director | 3,851,507 | S-Sale | D | 110,000 | 8.50 | 934,615.00 |
| 2022-12-31 | Carter Todd Alfred | officer: Chief Scientific Officer | 36,582 | A-Award | A | 388 | 5.17 | 2,006.00 |
| 2023-01-06 | Carter Todd Alfred | officer: Chief Scientific Officer | 36,194 | S-Sale | D | 388 | 6.41 | 2,487.00 |
| 2023-01-01 | Colon Grace | director | 44,000 | A-Award | A | 44,000 | 0.00 | 0.00 |
| 2023-01-01 | Colon Grace | None | 0 | None | None | 0.00 | ||
| 2023-01-01 | Colon Grace | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-10-01 | PFREUNDSCHUH PETER P. | officer: Chief Financial Officer | 125,000 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2022-08-24 | TEPPER ROBERT I | director: | 5,428,933 | S-Sale | D | 200,000 | 6.22 | 1,244,000.00 |
| 2022-08-16 | TEPPER ROBERT I | director: | 5,778,905 | S-Sale | D | 128,456 | 6.04 | 775,874.00 |
| 2022-08-15 | MACKEY CATHERINE J | director: | 44,000 | A-Award | A | 44,000 | 0.00 | 0.00 |
| 2022-08-15 | MACKEY CATHERINE J | director | 44,000 | A-Award | A | 44,000 | 6.02 | 264,880.00 |
| 2022-08-15 | MACKEY CATHERINE J | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-08-12 | TEPPER ROBERT I | director: | 5,907,361 | S-Sale | D | 135,808 | 6.04 | 820,280.00 |
| 2022-07-14 | PIERCE GLENN | director: | 16,788 | S-Sale | D | 9,512 | 6.70 | 63,730.00 |
| 2022-07-14 | Higgins Michael J | director: | 31,314 | S-Sale | D | 13,891 | 6.70 | 93,070.00 |
| 2022-06-21 | EcoR1 Capital, LLC | director: | 4,753,907 | P-Purchase | A | 376,000 | 5.66 | 2,126,543.00 |
| 2022-06-21 | EcoR1 Capital, LLC | 10 percent owner | 4,377,907 | P-Purchase | A | 101,400 | 5.28 | 535,504.00 |
| 2022-06-06 | GERAGHTY JAMES A | director: | 22,000 | A-Award | A | 22,000 | 0.00 | 0.00 |
| 2022-06-06 | GERAGHTY JAMES A | director | 22,000 | A-Award | A | 22,000 | 5.27 | 115,940.00 |
| 2022-06-06 | Hyman Steven | director: | 22,000 | A-Award | A | 22,000 | 0.00 | 0.00 |
| 2022-06-06 | Higgins Michael J | director: | 22,000 | A-Award | A | 22,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
